Skip to content

Four Directions

Seven Continents,

First Remedy,
Only Remedy

Rare
Diseases

Effective
Solutions

Suitable
Treatment

For the treatment of diseases affecting very few people worldwide, Biem provides patients with medicines produced using the latest technology, without pursuing high profit margins.

Sterile Injectable
Manufacturing Site

State-of-the-Art
Production

PIC/S GMP
Certified

EU GMP and
US FDA compatible

Developed in collaboration with leading European engineering and design companies, Biem’s manufacturing infrastructure is built on high engineering standards, advanced technologies, and a GMP-compliant manufacturing approach. Designed with a focus on quality, efficiency, and sustainability, the production system fully meets the requirements of modern pharmaceutical manufacturing.

Licensing and Market Authorization

Biem operates in Türkiye and international markets with expertise in the licensing, regulatory affairs, and marketing of pharmaceutical products. Through its strong business partnerships, the company efficiently and sustainably supports the market access of its products across diverse global markets.

Pharmaceutical Manufacturing, Marketing and Distribution

With its high-value pharmaceutical product portfolio serving both local and global markets, Biem manages manufacturing, distribution, and marketing process while also developing strategic partnerships with international pharmaceutical companies expanding into the local market.

Biem Worldwide

Biem’s international success is driven by its strategic focus on the pharmaceutical industry and its long-term investments in growth and innovation. Expanding beyond the Turkish market, Biem continues to operate steadily across global markets, supported by a strong international presence.

Therapeutic Areas

Biem’s Growth Journey

Founded in Ankara in 1991, Biem has evolved into a powerful, manufacturing-driven organization dedicated to quality and continuity in the pharmaceutical industry. Starting with biological pharmaceuticals, the company has driven steady, sustainable growth into licensed product manufacturing and establishing strong international partnerships.

MORE INFORMATION

Manufacturing Site

Biem’s state-of-the-art manufacturing facility, located in the Çerkezköy Organized Industrial Zone, operates with advanced production lines and an infrastructure that complies with international quality standards. Supported by stringent quality control processes and high hygiene standards, the facility ensures the reliable production of pharmaceuticals of the highest quality. With its strong manufacturing capacity, Biem continues to create sustainable value for healthcare in Türkiye and global markets.

MORE INFORMATION

Research & Development

BİEM R&D became actively operational in 2019 and was established to collaborate with the global pharmaceutical industry through its high-tech laboratory, scientific expertise, and innovative mindset. In line with European Medicines Agency (EMA) and United States Food and Drug Administration (US FDA) standards, BİEM R&D develops new and generic pharmaceutical products as well as manufacturing processes, transfers the technologies it develops to pharmaceutical manufacturing facilities, and conducts co-development projects with strategic partners operating in Türkiye, the European Union, and the United States.

MORE INFORMATION

News & Updates

Visit Us at CPhI 2026

Join us in Italy from 6–8 October 2026 to explore our innovative pharmaceutical solutions and discover new opportunities for global collaboration.

Read More

Strategic Partnerships

Biem recognizes that strong partnerships are one of the key drivers of success in the pharmaceutical industry. As part of its commitment to sustainable growth, the company establishes strategic partnerships that create mutual value throughout the sourcing, development, and commercialization of pharmaceutical products.

BUSINESS DEVELOPMENT